BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36967455)

  • 21. Logistic matrix factorisation and generative adversarial neural network-based method for predicting drug-target interactions.
    Abbou SI; Bouziane H; Chouarfia A
    Mol Divers; 2021 Aug; 25(3):1497-1516. PubMed ID: 34297278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BACPI: a bi-directional attention neural network for compound-protein interaction and binding affinity prediction.
    Li M; Lu Z; Wu Y; Li Y
    Bioinformatics; 2022 Mar; 38(7):1995-2002. PubMed ID: 35043942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. circRNA-binding protein site prediction based on multi-view deep learning, subspace learning and multi-view classifier.
    Li H; Deng Z; Yang H; Pan X; Wei Z; Shen HB; Choi KS; Wang L; Wang S; Wu J
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34571539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient machine learning model for predicting drug-target interactions with case study for Covid-19.
    El-Behery H; Attia AF; El-Feshawy N; Torkey H
    Comput Biol Chem; 2021 Aug; 93():107536. PubMed ID: 34271420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DeepFusion: A deep learning based multi-scale feature fusion method for predicting drug-target interactions.
    Song T; Zhang X; Ding M; Rodriguez-Paton A; Wang S; Wang G
    Methods; 2022 Aug; 204():269-277. PubMed ID: 35219861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ChemBoost: A Chemical Language Based Approach for Protein - Ligand Binding Affinity Prediction.
    Özçelik R; Öztürk H; Özgür A; Ozkirimli E
    Mol Inform; 2021 May; 40(5):e2000212. PubMed ID: 33225594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DeepDTAF: a deep learning method to predict protein-ligand binding affinity.
    Wang K; Zhou R; Li Y; Li M
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33834190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDF-DTA: A Multi-Dimensional Fusion Approach for Drug-Target Binding Affinity Prediction.
    Ranjan A; Bess A; Alvin C; Mukhopadhyay S
    J Chem Inf Model; 2024 Jul; 64(13):4980-4990. PubMed ID: 38888163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-Target Interaction Prediction: End-to-End Deep Learning Approach.
    Monteiro NRC; Ribeiro B; Arrais JP
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(6):2364-2374. PubMed ID: 32142454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compound-protein interaction prediction with end-to-end learning of neural networks for graphs and sequences.
    Tsubaki M; Tomii K; Sese J
    Bioinformatics; 2019 Jan; 35(2):309-318. PubMed ID: 29982330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving Protein-Ligand Interaction Modeling with cryo-EM Data, Templates, and Deep Learning in 2021 Ligand Model Challenge.
    Giri N; Cheng J
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Convolutional neural network based on SMILES representation of compounds for detecting chemical motif.
    Hirohara M; Saito Y; Koda Y; Sato K; Sakakibara Y
    BMC Bioinformatics; 2018 Dec; 19(Suppl 19):526. PubMed ID: 30598075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Machine learning prediction of oncology drug targets based on protein and network properties.
    Dezső Z; Ceccarelli M
    BMC Bioinformatics; 2020 Mar; 21(1):104. PubMed ID: 32171238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial intelligence in the prediction of protein-ligand interactions: recent advances and future directions.
    Dhakal A; McKay C; Tanner JJ; Cheng J
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34849575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based drug design with geometric deep learning.
    Isert C; Atz K; Schneider G
    Curr Opin Struct Biol; 2023 Apr; 79():102548. PubMed ID: 36842415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of Data Selection in Deep Learning for Reliable Binding Mode Prediction of Ligands in the Active Site of CYP3A4.
    Sato A; Tanimura N; Honma T; Konagaya A
    Chem Pharm Bull (Tokyo); 2019 Nov; 67(11):1183-1190. PubMed ID: 31423003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DeepFusionDTA: Drug-Target Binding Affinity Prediction With Information Fusion and Hybrid Deep-Learning Ensemble Model.
    Pu Y; Li J; Tang J; Guo F
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(5):2760-2769. PubMed ID: 34379594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CoaDTI: multi-modal co-attention based framework for drug-target interaction annotation.
    Huang L; Lin J; Liu R; Zheng Z; Meng L; Chen X; Li X; Wong KC
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36274236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Machine learning in computational docking.
    Khamis MA; Gomaa W; Ahmed WF
    Artif Intell Med; 2015 Mar; 63(3):135-52. PubMed ID: 25724101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A learning-based method for drug-target interaction prediction based on feature representation learning and deep neural network.
    Peng J; Li J; Shang X
    BMC Bioinformatics; 2020 Sep; 21(Suppl 13):394. PubMed ID: 32938374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.